NIH Genetic Testing Registry (GTR) now accepting microbe tests including SARS-CoV-2 / COVID-19 tests
NCBI, September 2020
NCBI, September 2020
The profound impact of the COVID-19 pandemic prompted the NIH Genetic Testing Registry (GTR) to expand its scope to include microbe tests. We will focus initially on molecular tests to detect the SARS-CoV-2 virus and serology tests to detect viral antigens and antibodies to the virus.
No hay comentarios:
Publicar un comentario